Indications for: ZINPLAVA

To reduce recurrence of Clostridioides difficile infection (CDI) in patients who are receiving antibacterial drug treatment of CDI and are at high risk for CDI recurrence.

Limitations of Use:

Not for treating CDI. Use only in conjunction with antibacterial drug treatment of CDI.

Adult Dosage:

Infuse over 60mins. ≥18yrs: a single dose of 10mg/kg.

Children Dosage:

<18yrs: not established.

ZINPLAVA Warnings/Precautions:

History of CHF. Pregnancy. Nursing mothers.

ZINPLAVA Classification:

Human IgG1 monoclonal antibody.

Adverse Reactions:

Nausea, pyrexia, headache, infusion-related reactions; heart failure.

Generic Drug Availability:


How Supplied:

Single-dose vial (40mL)—1